Building capacity in stem cell research

Sunderarajan Padmanabhan New Delhi | Updated on January 17, 2020 Published on January 17, 2020

Department of Biotechnology’s Bengaluru-based Institute for Stem Cell Science and Regenerative Medicine (inStem) is conducting a 10-day laboratory workshop on `Reprogramming human somatic cells to induced pluripotent stem cells’ from January 15 to 24.

The workshop is part of an effort to train and build capacity in stem cell research in the country.

Nine researchers from different institutions across the country are receiving hands-on training at the workshop. It focused on techniques involved in the generation and maintenance of high-quality human induced pluripotent stem cells from human somatic cells. The course combines hands-on laboratory training sessions and lectures from experts in the field.

The training has been organised under the aegis of the Accelerator program for Discovery in Brain disorders using Stem cells (ADBS), which aims to promote research in the area of mental illness by harnessing the power of sophisticated clinical investigations, modern human genetics, and stem cell technology.

The programme was launched in 2016 under the joint stewardship of Institute for Stem Cell Biology and Regenerative Medicine, National Centre for Biological Sciences and National Institute for Mental Health and Neurosciences. It is supported by Department of Biotechnology and Pratiksha Trust founded by Mr. Kris Gopalakrishnan and Mrs. Sudha Gopalakrishnan.

(India Science Wire)

Twitter handle: @ndpsr

Published on January 17, 2020

A letter from the Editor

Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
This article is closed for comments.
Please Email the Editor
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.